# What Is Peptide Therapy? Benefits, How It Works & What to Expect **By TelosRX Editorial Team** · 2026-09-13 **[Peptide therapy](https://www.telosrx.com) uses short chains of amino acids — the building blocks of proteins — to support specific biological functions including tissue repair, hormone signaling, immune modulation, and metabolic function. It is available through licensed telehealth providers and is subject to medical approval by a licensed provider.** If you've seen peptides mentioned alongside TRT, GLP-1 programs, or longevity protocols and wondered what they actually are and whether they work, this guide covers the fundamentals: what peptides are, how different classes work, what the clinical literature says, and what the evaluation process looks like. ## What Are Peptides? Peptides are short chains of amino acids — typically 2 to 50 — linked by peptide bonds. Proteins are also amino acid chains, but longer and more structurally complex. Peptides are small enough to interact with specific cell receptors and signal precise biological responses without the systemic footprint of whole proteins. Your body already produces hundreds of peptides naturally: insulin (51 amino acids), glucagon-like peptide-1 (GLP-1), growth hormone-releasing hormone (GHRH), and many others. Peptide therapy applies this same signaling logic using synthetic or bioidentical peptide sequences to support or restore processes that decline with age, injury, or dysfunction. Therapeutic peptides are typically administered subcutaneously (small insulin-style injections), though some are available as nasal sprays, oral capsules, or topical preparations depending on the compound. ## How Does Peptide Therapy Work? Peptides work by binding to specific receptors on cell surfaces or within cells and triggering downstream biological responses. The specificity is the key distinction from broader interventions: a peptide targeting growth hormone secretagogue receptors stimulates growth hormone release from the pituitary without affecting cortisol, insulin, or other axes in the same way. Different peptide classes target different pathways: - **Growth hormone secretagogues** (sermorelin, ipamorelin, CJC-1295): Stimulate the pituitary to release growth hormone in a pulsatile, physiologic pattern. Used to support body composition, recovery, and sleep quality. - **Tissue repair peptides** (BPC-157, TB-500): Promote angiogenesis, collagen synthesis, and cellular repair. Research is largely preclinical but used clinically for musculoskeletal recovery. - **Metabolic peptides** (GLP-1 agonists, AOD-9604): Affect appetite regulation, fat metabolism, and blood glucose management. - **Anti-inflammatory peptides** (KPV, thymosin beta-4 fragments): Modulate cytokine responses and inflammatory signaling pathways. - **Cognitive and neurological peptides** (selank, semax): Influence neurotransmitter activity and neuroprotective pathways. The mechanism matters for understanding why peptides have different safety profiles and evidence bases than synthetic hormones or small-molecule pharmaceuticals. They mimic or support existing signaling pathways rather than overriding them. ## What Are the Benefits of Peptide Therapy? Benefits depend heavily on which peptide is used and why. A general overview: ### Growth Hormone Support GH secretagogues like sermorelin and the ipamorelin/CJC-1295 stack are among the most commonly used peptides. Research supports their ability to increase IGF-1 (the primary mediator of GH effects), improve lean body mass, support fat metabolism, and improve sleep architecture. A 2019 review in _Growth Hormone & IGF Research_ confirmed sermorelin's efficacy in raising GH and IGF-1 in adults with deficiency. ### Tissue Repair and Recovery BPC-157 (body protective compound) has shown consistent results in preclinical studies for accelerating tendon, ligament, and GI tract healing. Animal models show meaningful improvement in healing speed and quality. Clinical human trials are limited but ongoing; provider review determines appropriateness on a case-by-case basis. See our full guide: [BPC-157: Patient Guide for 2026](https://www.telosrx.com/blogs/peptides/bpc-157-peptide-patient-guide-pcac-2026). ### Body Composition GH peptides support lean mass preservation and fat metabolism, particularly in the context of lifestyle interventions. They are often used alongside testosterone replacement or GLP-1 programs as complementary metabolic support. ### Recovery and Sleep Ipamorelin in particular is associated with improved deep sleep stages because GH is predominantly released during slow-wave sleep — and GH secretagogues amplify the body's natural nocturnal GH pulse. ### Inflammatory Regulation Peptides such as KPV (a tripeptide derived from alpha-MSH) have shown anti-inflammatory effects in gut tissue in preclinical research, relevant for conditions involving intestinal inflammation. ## What Does the Research Say? The evidence base for peptide therapy varies significantly by compound: - **GLP-1 agonists**: Extensive RCT data across STEP, SELECT, and SURMOUNT trials (thousands of participants, multi-year follow-up). The most clinically validated peptide class. - **Sermorelin / GH secretagogues**: Phase II and Phase III RCT data supporting GH and IGF-1 elevation. Longer-term outcomes data is more limited than GLP-1 compounds. - **BPC-157 / TB-500**: Robust preclinical (animal) literature; human RCT data is emerging. Not FDA-approved; available through compounding pharmacies. - **KPV, selank, semax**: Early-stage research; clinical use is ahead of large-scale trial data. Peptides available through compounded pharmacies are not FDA-approved. They are prepared under federal compounding regulations. The clinical application draws on mechanism of action, preclinical data, and provider clinical judgment — not an FDA-reviewed label indication. Source: [Laron, "Peptide and non-peptide analogs — growth hormone secretagogues," Eur J Endocrinol 2008](https://pubmed.ncbi.nlm.nih.gov/29024676/) Source: [Sikiric et al., "Stable gastric pentadecapeptide BPC 157," Curr Pharm Des 2018](https://pubmed.ncbi.nlm.nih.gov/27421966/) ## Who Is a Candidate for Peptide Therapy? Peptide therapy is typically considered for adults experiencing: - Age-related declines in recovery, muscle maintenance, or energy despite adequate lifestyle factors - Suboptimal growth hormone or IGF-1 on labs, short of diagnosable GH deficiency - Chronic musculoskeletal issues not fully resolved with standard care (relevant for tissue-repair peptides) - Inflammatory or metabolic conditions where peptide mechanisms align with the underlying issue - Optimization goals alongside an existing hormonal or metabolic program (TRT, GLP-1, etc.) Peptide therapy is not appropriate for everyone. Contraindications include active malignancy (GH-stimulating peptides may theoretically promote tumor growth), pregnancy, and certain autoimmune conditions depending on the compound. Provider evaluation determines appropriateness. For a comparison of growth hormone-stimulating options, see: [CJC-1295 + Ipamorelin: Growth Hormone Stack Research](https://www.telosrx.com/blogs/peptides/cjc-1295-ipamorelin-growth-hormone-stack-research). ## What to Expect: The Evaluation and Treatment Process Peptide therapy through an asynchronous telehealth provider like TelosRX works as follows: 1. **Intake and history review:** You submit your health history, current medications, and goals. The provider reviews for contraindications and establishes a baseline. 2. **Lab review (if applicable):** For GH peptides, IGF-1 baseline is typically reviewed. For broader longevity programs, a panel including metabolic markers, hormones, and inflammatory markers may be requested. 3. **Provider evaluation:** A licensed provider reviews your file asynchronously and determines whether peptide therapy is appropriate and which compounds are indicated. 4. **Prescription and dispensing:** If approved, compounded peptides are prescribed and dispensed by a licensed compounding pharmacy. Shipping is typically included. 5. **Ongoing monitoring:** Follow-up labs and check-ins are scheduled based on the protocol. Dose adjustments are made as needed based on response and labs. Timeline expectations vary by compound. GH peptides typically show subjective improvements in sleep within 2–4 weeks, with measurable IGF-1 changes at 6–8 weeks. Tissue repair peptides may show effects within 4–8 weeks depending on the injury and dose. Individual results vary. For sermorelin specifically, see: [Sermorelin: Growth Hormone Peptide Research Guide](https://www.telosrx.com/blogs/hormone-longevity/sermorelin-growth-hormone-peptide-research-guide). ## Frequently Asked Questions ### What is peptide therapy used for? Peptide therapy is used for a range of goals including growth hormone support, tissue repair and recovery, metabolic function, body composition, anti-inflammatory effects, and cognitive support. The application depends on which peptide is used and the individual's medical history. All use requires evaluation and approval by a licensed provider. ### Is peptide therapy safe? Safety varies by peptide class and individual profile. GH secretagogues like sermorelin have Phase II/III clinical trial data supporting their safety profile. BPC-157 and similar tissue-repair peptides have extensive preclinical safety data and limited human clinical trials. All compounded peptides are not FDA-approved and are evaluated on a case-by-case basis by a licensed provider. Side effects depend on the specific compound, dose, and administration route. ### Are peptides the same as steroids? No. Peptides are short amino acid chains that signal biological processes — they don't function as steroid hormones. Growth hormone secretagogues, for example, stimulate the pituitary to produce growth hormone naturally rather than introducing synthetic hormones. The mechanism, legal status, and clinical profile are entirely different from anabolic steroids. ### How are therapeutic peptides administered? Most therapeutic peptides are administered via subcutaneous injection (similar to insulin — small gauge needle, injected under the skin). Some peptides are available as nasal sprays or oral capsules. The administration method depends on the compound's molecular weight and stability; many peptides are degraded by digestive enzymes and require injection to remain bioavailable. ### How long does peptide therapy take to work? Timeline varies by peptide and goal. Growth hormone secretagogues typically show subjective improvements in sleep and recovery within 2–4 weeks, with measurable IGF-1 elevations at 6–8 weeks. BPC-157 for musculoskeletal recovery may show effect within 4–8 weeks. Optimal results often require 3–6 months of consistent use. Individual results vary. ### Can peptides be used with TRT or GLP-1 medications? Yes, peptides are frequently used alongside testosterone replacement therapy and GLP-1 medications as part of a broader optimization program. The protocols require provider review for potential interactions and appropriate dosing across compounds. TelosRX evaluates each patient's full medication and supplement list as part of the intake process. _TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._ Start your private evaluation at [TelosRX](https://telosrx.com). **Tags:** BPC-157, GH peptides, peptide therapy, sermorelin, telehealth, tissue repair, what is peptide therapy --- > Source: [Telos RX](https://www.telosrx.com/blogs/peptides/what-is-peptide-therapy-guide)